Key result
Hyperinsulinemia, hyperleptinemia, and chronic inflammation drive carotid body dysfunction in obesity and type 2 diabetes.
Why the study?
Carotid body dysfunction is implicated in metabolic diseases, prompting a review of the putative pathways linking chemoreceptor deregulation with metabolic pathogenesis and the roles of hyperinsulinemia, hyperleptinemia, and chronic inflammation.
This review highlights the mechanistic pathways linking carotid body chemoreceptor deregulation with the pathogenesis of metabolic diseases, suggesting therapeutic potential for modulating carotid body activity.
Suggests carotid body modulation as a therapeutic target in metabolic disease; leaves open clinical efficacy pending prospective trials.
, and pH levels. Apart from ventilatory control, these organs are deeply involved in the homeostatic regulation of carbohydrates and lipid metabolism and inflammation. It has been described that CB dysfunction is involved in the genesis of metabolic diseases and that CB overactivation is present in animal models of metabolic disease and in prediabetes patients. Additionally, resection of the CB-sensitive nerve, the carotid sinus nerve (CSN), or CB ablation in animals prevents and reverses diet-induced insulin resistance and glucose intolerance as well as sympathoadrenal overactivity, meaning that the beneficial effects of decreasing CB activity on glucose homeostasis are modulated by target-related efferent sympathetic nerves, through a reflex initiated in the CBs. In agreement with our pre-clinical data, hyperbaric oxygen therapy, which reduces CB activity, improves glucose homeostasis in type 2 diabetes patients. Insulin, leptin, and pro-inflammatory cytokines activate the CB. In this manuscript, we review in a concise manner the putative pathways linking CB chemoreceptor deregulation with the pathogenesis of metabolic diseases and discuss and present new data that highlight the roles of hyperinsulinemia, hyperleptinemia, and chronic inflammation as major factors contributing to CB dysfunction in metabolic disorders.
No takes yet. Share an insight, caveat, or question.
Sacramento et al. (2020) conducted a review in Type 2 diabetes and obesity-related syndromes. Hyperinsulinemia, hyperleptinemia, and chronic inflammation was evaluated. Hyperinsulinemia, hyperleptinemia, and chronic inflammation are major mediators that contribute to carotid body dysfunction in type 2 diabetes and obesity-related syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: